Physician profile
Ilya Gorbachinsky
NPI 1588959977
$10,832.59
in general payments reported to CMS, 2019-2025
43 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,683 · 2020: $514 · 2021: $1,380 · 2022: $1,549 · 2023: $1,831 · 2024: $1,592 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,520 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,519.74 |
| Education | $186.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,564.65 | 2019-2025 | Provenge |
| Neotract INC. | $1,470.04 | 2019-2020 | |
| Astellas Pharma US INC | $1,300.85 | 2019-2025 | Myrbetriq, Xtandi, Padcev |
| Sumitomo Pharma America, INC. | $959.98 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $495.52 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $479.16 | 2019-2025 | |
| Janssen Biotech, INC. | $459.76 | 2019-2025 | Erleada |
| Abbvie INC. | $454.48 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $416.93 | 2021-2025 | Prolaris |
| Telix Pharmaceuticals | $316.46 | 2024-2025 | Illuccix |
| Myovant Sciences INC. | $298.51 | 2021-2022 | |
| Boston Scientific Corporation | $237.80 | 2019-2025 | Moses, Rezum Generator, Spaceoar Vue System - 10ml |
| Teleflex LLC | $233.95 | 2021-2024 | Urolift |
| Urogen Pharma, INC. | $227.42 | 2021-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $191.90 | 2020-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $175.96 | 2019-2024 | Xiaflex |
| Medtronic, INC. | $161.67 | 2025 | Interstim |
| Urovant Sciences INC | $157.79 | 2021-2022 | |
| Amgen INC. | $135.79 | 2021-2023 | Xgeva |
| 180 Medical, INC. | $120.17 | 2019-2025 | |
| Abbott Laboratories | $120.02 | 2023 | Cardiomems |
| Accord Healthcare, INC. | $97.41 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $92.78 | 2019-2024 | Adstiladrin |
| Coloplast Corp | $80.42 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $70.73 | 2019-2022 | |
| Allergan, INC. | $68.64 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $60.54 | 2020-2024 | Keytruda, Welireg |
| Endo USA, INC. | $59.90 | 2024-2025 | Xiaflex |
| Axonics, INC. | $45.45 | 2021-2024 | Axonics, Bulkamid |
| Alnylam Pharmaceuticals INC. | $43.06 | 2021-2022 | |
| Blue Earth Diagnostics | $29.36 | 2019-2022 | |
| Hollister Incorporated | $24.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.13 | 2021 | |
| Photocure INC | $23.54 | 2019 | |
| Procept Biorobotics Corporation | $19.85 | 2024 | Aquabeam System |
| Shionogi INC | $18.70 | 2022 | |
| Convatec INC. | $18.13 | 2021 | |
| Laborie Medical Technologies Corp. | $15.97 | 2025 | Optilume Urethral Drug Coated Balloon |
| Srs Medical Systems, INC. | $15.65 | 2019 | |
| Cycle Pharmaceuticals INC | $13.95 | 2024 | Tiopronin |
| Kowa Pharmaceuticals America, INC. | $13.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Mission Pharmacal Company | $6.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Gorbachinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.